MarketInOut Stock Screener Log In | Sign Up

Recordati S.p.A.

MIL • Healthcare • Drug Manufacturers - General • Quote as of 10/27/2026 17:35
Recordati S.p.A. stock price and volume chart

Company Profile

IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeMIL
Market Capitalization11,014 mln
Float99.19 mln
Earnings Date11/10/2026

EPS

2.38
Solid

P / E

22.29
Premium valuation

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-2.53
Likely reliable

1-Year Forecast

60.22
Modest upside

Relative Strength

79 / 100
Strongly outperforming

Business Description

Recordati is an Italian pharmaceutical company founded in 1926 and headquartered in Milan, with operations spanning Europe, North America, Russia, Turkey, North Africa, and beyond. The company works across two main areas: treatments for common conditions such as high blood pressure, prostate problems, and cholesterol, and therapies for rare diseases including certain metabolic disorders, hormone imbalances, and specific cancers. Its portfolio includes both established medications and products currently in clinical development.

Key Fundamentals

EPS2.38
P/E22.29
ROE25.13
RPS13.24
ROIC13.67
ROA9.41
Interest Cover8.41
EBITDA, mln965
EV / EBITDA13.45
EV / EBIT17.19
Revenue, mln2,705
EV / Revenue4.80

Quote Details

Last 52.75
Change -0.25 (-0.47%)
Open 53.10
Volume 123,313
Turnover 6,504,761
Average Volume 348,104

Financial Ratios

Pre-Tax Profit Margin24
Leverage Ratio2.52
Current Ratio1.26
Price / Book5.06
Price / Cash Flow16.71
Price / Free Cash Flow18.33
Debt / Equity1.08
Price / Sales4.06
PEG Ratio2.02

Financial Strength

Altman Z-Score3.71
Piotroski F-Score 6 / 9
Beneish M-Score-2.53
Price to Intrinsic Value1.23
Price to Lynch Fair Value1.69
1-Year Target Price60.22
Shiller PE Ratio26.57

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -0.47% 82 / 100   
1 Month -0.75% 75 / 100   
2 Months 2.73% 77 / 100   
6 Months 7.24% 73 / 100   
1 Year 6.93% 63 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog